dimercaprol has been researched along with Delirium in 4 studies
Dimercaprol: An anti-gas warfare agent that is effective against Lewisite (dichloro(2-chlorovinyl)arsine) and formerly known as British Anti-Lewisite or BAL. It acts as a chelating agent and is used in the treatment of arsenic, gold, and other heavy metal poisoning.
dimercaprol : A dithiol that is propane-1,2-dithiol in which one of the methyl hydrogens is replaced by a hydroxy group. a chelating agent originally developed during World War II as an experimental antidote against the arsenic-based poison gas Lewisite, it has been used clinically since 1949 for the treatment of poisoning by arsenic, mercury and gold. It can also be used for treatment of poisoning by antimony, bismuth and possibly thallium, and (with sodium calcium edetate) in cases of acute leaad poisoning. Administration is by (painful) intramuscular injection of a suspension of dimercaprol in peanut oil, typically every 4 hours for 2-10 days depending on the toxicity. In the past, dimercaprol was also used for the treatment of Wilson's disease, a severely debilitating genetic disorder in which the body tends to retain copper, with resultant liver and brain injury.
Delirium: A disorder characterized by CONFUSION; inattentiveness; disorientation; ILLUSIONS; HALLUCINATIONS; agitation; and in some instances autonomic nervous system overactivity. It may result from toxic/metabolic conditions or structural brain lesions. (From Adams et al., Principles of Neurology, 6th ed, pp411-2)
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 50-year-old chemical engineer, routinely screened for occupational arsenic exposure, was admitted with a delirium for which no known etiology was found." | 3.67 | Neuropsychological impairment following inorganic arsenic exposure. ( Bleecker, ML; Bolla-Wilson, K, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| ABDEL-GHAFFAR, Y | 1 |
| SHERIF, YA | 1 |
| EL-MASSRY, ZH | 1 |
| BARSOOM, KA | 1 |
| Mattle, H | 1 |
| Henn, V | 1 |
| Baumgartner, G | 1 |
| Dubowitz, MN | 1 |
| Hughes, PJ | 1 |
| Lane, RJ | 1 |
| Wade, JP | 1 |
| Bolla-Wilson, K | 1 |
| Bleecker, ML | 1 |
4 other studies available for dimercaprol and Delirium
| Article | Year |
|---|---|
LEAD ENCEPHALOPATHY: CASE REPORT.
Topics: Blood Chemical Analysis; Coma; Delirium; Dimercaprol; Lead Poisoning; Neurologic Examination; Neurot | 1963 |
[Acute delirium in bismuth poisoning].
Topics: Bismuth; Chelating Agents; Delirium; Dexamethasone; Diagnosis, Differential; Dimercaprol; Drug Thera | 1982 |
Gold-induced neuroencephalopathy responding to dimercaprol.
Topics: Arthritis, Rheumatoid; Delirium; Dimercaprol; Drug Administration Schedule; Gold Sodium Thiomalate; | 1991 |
Neuropsychological impairment following inorganic arsenic exposure.
Topics: Arsenic; Auditory Perceptual Disorders; Cognition Disorders; Consciousness Disorders; Delirium; Dime | 1987 |